Profile data is unavailable for this security.
About the company
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
- Revenue in USD (TTM)82.20m
- Net income in USD13.91m
- Incorporated2018
- Employees288.00
- LocationAnika Therapeutics Inc32 Wiggins AveBEDFORD 01730-2315United StatesUSA
- Phone+1 (781) 457-9000
- Fax+1 (781) 305-9720
- Websitehttps://anika.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nano-X Imaging Ltd | 12.30m | -55.71m | 179.25m | 165.00 | -- | 1.08 | -- | 14.57 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Accendra Health Inc | 4.72bn | -123.85m | 183.45m | 6.50k | -- | -- | 1.40 | 0.0389 | -1.61 | -14.30 | 61.33 | -6.03 | 1.33 | 45.41 | 30.05 | 726,184.00 | -3.48 | -0.9299 | -5.75 | -1.46 | 31.70 | 25.69 | -2.62 | -0.723 | 0.4999 | 1.08 | 1.29 | -- | 3.06 | -20.10 | 70.72 | -- | 27.74 | -- |
| InfuSystem Holdings Inc | 143.44m | 6.63m | 185.58m | 502.00 | 29.12 | 3.24 | 9.30 | 1.29 | 0.3153 | 0.3153 | 6.81 | 2.84 | 1.41 | 10.59 | 6.51 | -- | 6.49 | 2.25 | 7.97 | 2.69 | 55.98 | 54.61 | 4.62 | 1.83 | 1.53 | 9.37 | 0.255 | -- | 6.36 | 8.05 | 182.60 | -17.49 | -12.48 | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 187.93m | 163.00 | -- | 4.24 | -- | 6.16 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 189.84m | 72.00 | -- | -- | -- | 43.16 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Electromed Inc | 68.86m | 8.99m | 198.44m | 177.00 | 23.34 | 4.37 | 19.48 | 2.88 | 1.03 | 1.03 | 7.86 | 5.49 | 1.28 | 4.59 | 2.69 | 389,045.20 | 16.78 | 9.33 | 20.17 | 11.04 | 78.23 | 76.56 | 13.06 | 8.40 | 4.49 | -- | 0.00 | 0.00 | 16.97 | 14.53 | 46.35 | 12.62 | -20.72 | -- |
| Stereotaxis Inc | 30.07m | -24.91m | 199.72m | 139.00 | -- | 31.11 | -- | 6.64 | -0.281 | -0.281 | 0.3393 | 0.1266 | 0.6232 | 1.47 | 4.54 | 216,359.70 | -48.96 | -31.30 | -85.25 | -43.31 | 53.07 | 62.81 | -78.56 | -56.04 | 0.8108 | -- | 0.00 | -- | 0.5491 | -1.41 | -14.95 | -- | 2.89 | -- |
| SANUWAVE Health Inc | 41.28m | -7.04m | 202.65m | 46.00 | -- | -- | -- | 4.91 | -0.9346 | -0.9346 | 4.68 | -0.3418 | 1.44 | 1.75 | 11.07 | 897,456.50 | -24.53 | -124.81 | -- | -- | 78.26 | 71.67 | -17.06 | -144.71 | 0.808 | 0.0999 | 1.14 | -- | 59.99 | 99.65 | -21.56 | -- | 55.47 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 207.67m | 288.00 | 15.29 | 1.41 | 10.27 | 2.53 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| Utah Medical Products Inc | 38.63m | 11.62m | 211.92m | 155.00 | 18.81 | 1.80 | 14.57 | 5.49 | 3.54 | 3.54 | 11.75 | 36.91 | 0.307 | 1.92 | 10.38 | 249,245.20 | 9.24 | 12.08 | 9.48 | 12.53 | 57.10 | 60.88 | 30.08 | 31.04 | 29.36 | -- | 0.00 | 37.43 | -18.56 | -2.70 | -16.60 | -0.8254 | -59.49 | 1.83 |
| OraSure Technologies Inc | 125.70m | -60.24m | 213.77m | 501.00 | -- | 0.5949 | -- | 1.70 | -0.8107 | -0.8107 | 1.69 | 5.01 | 0.2834 | 2.07 | 4.91 | 250,904.20 | -13.08 | -0.8506 | -14.16 | -0.9596 | 40.41 | 44.80 | -46.15 | -1.39 | 6.20 | -- | 0.0005 | -- | -54.17 | 3.75 | -136.34 | -- | -16.43 | -- |
| CVRx Inc | 56.65m | -53.31m | 215.23m | 223.00 | -- | 5.47 | -- | 3.80 | -2.04 | -2.04 | 2.17 | 1.49 | 0.4756 | 0.6837 | 5.68 | 254,040.40 | -44.76 | -39.12 | -49.79 | -42.10 | 85.33 | 82.74 | -94.10 | -130.77 | 6.72 | -8.80 | 0.5574 | -- | 10.45 | 56.40 | 11.10 | -- | 13.27 | -- |
| KORU Medical Systems Inc | 39.07m | -3.71m | 220.96m | 80.00 | -- | 13.41 | -- | 5.66 | -0.0807 | -0.0807 | 0.8482 | 0.3557 | 1.43 | 3.53 | 7.39 | 488,383.00 | -13.62 | -19.85 | -18.41 | -23.16 | 62.32 | 59.62 | -9.50 | -24.86 | 1.92 | -- | 0.0335 | -- | 17.98 | 7.75 | 55.85 | -- | 25.82 | -- |
| 908 Devices Inc | 57.64m | -57.10m | 228.74m | 246.00 | -- | 1.67 | -- | 3.97 | -1.61 | -0.1116 | 1.62 | 3.77 | 0.3123 | 1.76 | 4.17 | 234,296.80 | -30.94 | -18.01 | -37.82 | -19.67 | 49.35 | 52.89 | -99.07 | -78.45 | 3.12 | -- | 0.00 | -- | 18.72 | 27.11 | -98.37 | -- | 8.96 | -- |
| Simulations Plus Inc | 78.68m | -64.25m | 238.94m | 212.00 | -- | 1.88 | -- | 3.04 | -3.20 | -3.20 | 3.90 | 6.31 | 0.4701 | -- | 4.28 | 371,113.20 | -38.39 | -2.50 | -40.84 | -2.65 | 59.60 | 69.96 | -81.66 | -7.29 | -- | -- | 0.00 | -- | 13.09 | 13.74 | -750.17 | -- | 7.57 | -24.21 |
| Cibus Inc | 3.79m | -118.90m | 239.69m | 157.00 | -- | 3.68 | -- | 63.18 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
Data as of Mar 04 2026. Currency figures normalised to Anika Therapeutics Inc's reporting currency: US Dollar USD
47.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Caligan Partners LPas of 23 Jan 2026 | 1.44m | 9.95% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 914.28k | 6.34% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 684.30k | 4.75% |
| BlackRock Financial Management, Inc.as of 31 Dec 2025 | 667.85k | 4.63% |
| Acadian Asset Management LLCas of 31 Dec 2025 | 606.54k | 4.21% |
| Boothbay Fund Management LLCas of 31 Dec 2025 | 534.51k | 3.71% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 519.94k | 3.61% |
| Renaissance Technologies LLCas of 31 Dec 2025 | 515.72k | 3.58% |
| The Capital Management Corp.as of 31 Dec 2025 | 500.47k | 3.47% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 480.42k | 3.33% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
